nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—PDE10A—Signaling by GPCR—WNT9B—cleft lip	0.00579	0.00579	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—FGF8—cleft lip	0.00575	0.00575	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—FGF8—cleft lip	0.00575	0.00575	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—FGF8—cleft lip	0.00569	0.00569	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—FGF8—cleft lip	0.00564	0.00564	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—FGF8—cleft lip	0.00562	0.00562	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—FGF7—cleft lip	0.00551	0.00551	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—FGF3—cleft lip	0.00537	0.00537	CbGpPWpGaD
Vardenafil—PDE1B—Phospholipase C-mediated cascade—FGF2—cleft lip	0.00528	0.00528	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—FGF9—cleft lip	0.00523	0.00523	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—WNT3—cleft lip	0.00516	0.00516	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—FGF8—cleft lip	0.00509	0.00509	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—FGF3—cleft lip	0.00504	0.00504	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—FGF3—cleft lip	0.00502	0.00502	CbGpPWpGaD
Vardenafil—PDE6G—Disease—WNT9B—cleft lip	0.00501	0.00501	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—FGF3—cleft lip	0.005	0.005	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—FGF3—cleft lip	0.00497	0.00497	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—FGF9—cleft lip	0.00492	0.00492	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—FGF9—cleft lip	0.00489	0.00489	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—FGF9—cleft lip	0.00487	0.00487	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—FGF9—cleft lip	0.00485	0.00485	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—FGF3—cleft lip	0.00468	0.00468	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—FGF3—cleft lip	0.00468	0.00468	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—FGF3—cleft lip	0.00463	0.00463	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—WNT3—cleft lip	0.0046	0.0046	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—FGF3—cleft lip	0.00459	0.00459	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—FGF3—cleft lip	0.00457	0.00457	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—FGF9—cleft lip	0.00456	0.00456	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—FGF9—cleft lip	0.00456	0.00456	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—FGF9—cleft lip	0.00452	0.00452	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—FGF9—cleft lip	0.00448	0.00448	CbGpPWpGaD
Vardenafil—PDE6G—Disease—ABCA4—cleft lip	0.00447	0.00447	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—FGF9—cleft lip	0.00446	0.00446	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—FGF10—cleft lip	0.00441	0.00441	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB3—cleft lip	0.00429	0.00429	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—FGF7—cleft lip	0.00424	0.00424	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—FGF10—cleft lip	0.00415	0.00415	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—FGF3—cleft lip	0.00414	0.00414	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—FGF10—cleft lip	0.00413	0.00413	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—FGF10—cleft lip	0.00411	0.00411	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—FGF10—cleft lip	0.00409	0.00409	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SLC19A1—cleft lip	0.00409	0.00409	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—FGF9—cleft lip	0.00404	0.00404	CbGpPWpGaD
Vardenafil—PDE1B—Platelet homeostasis—NOS3—cleft lip	0.00399	0.00399	CbGpPWpGaD
Vardenafil—PDE6G—Disease—WNT3—cleft lip	0.00398	0.00398	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—FGF8—cleft lip	0.00391	0.00391	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—FGF10—cleft lip	0.00385	0.00385	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—FGF10—cleft lip	0.00385	0.00385	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—WNT9B—cleft lip	0.00384	0.00384	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—FGF10—cleft lip	0.00381	0.00381	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—FGF10—cleft lip	0.00378	0.00378	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—FGF10—cleft lip	0.00376	0.00376	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOG—cleft lip	0.00368	0.00368	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—FGFR2—cleft lip	0.00354	0.00354	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—WNT9B—cleft lip	0.00351	0.00351	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ABCA4—cleft lip	0.00342	0.00342	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—WNT9B—cleft lip	0.00342	0.00342	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—FGF10—cleft lip	0.00341	0.00341	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TCN2—cleft lip	0.00339	0.00339	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOG—cleft lip	0.00337	0.00337	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—FGFR2—cleft lip	0.00333	0.00333	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—FGFR2—cleft lip	0.00331	0.00331	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—FGFR1—cleft lip	0.0033	0.0033	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—FGFR2—cleft lip	0.0033	0.0033	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—FGFR2—cleft lip	0.00328	0.00328	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOG—cleft lip	0.00328	0.00328	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—FGF3—cleft lip	0.00319	0.00319	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ARHGAP29—cleft lip	0.00316	0.00316	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ABCA4—cleft lip	0.00313	0.00313	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—FGFR3—cleft lip	0.00312	0.00312	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—FGF9—cleft lip	0.00311	0.00311	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—FGFR1—cleft lip	0.0031	0.0031	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—FGFR1—cleft lip	0.00309	0.00309	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—FGFR2—cleft lip	0.00309	0.00309	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—FGFR2—cleft lip	0.00309	0.00309	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—FGFR1—cleft lip	0.00307	0.00307	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—FGFR2—cleft lip	0.00306	0.00306	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—FGFR1—cleft lip	0.00306	0.00306	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—WNT3—cleft lip	0.00305	0.00305	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ABCA4—cleft lip	0.00305	0.00305	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—FGFR2—cleft lip	0.00303	0.00303	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—FGFR2—cleft lip	0.00302	0.00302	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—WNT9B—cleft lip	0.00294	0.00294	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—FGFR3—cleft lip	0.00293	0.00293	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—FGFR3—cleft lip	0.00292	0.00292	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—FGFR3—cleft lip	0.0029	0.0029	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—FGFR3—cleft lip	0.00289	0.00289	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—FGFR1—cleft lip	0.00288	0.00288	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—FGFR1—cleft lip	0.00288	0.00288	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—FGFR1—cleft lip	0.00285	0.00285	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—PTCH1—cleft lip	0.00283	0.00283	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—FGFR1—cleft lip	0.00283	0.00283	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—FGFR1—cleft lip	0.00281	0.00281	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—WNT3—cleft lip	0.00279	0.00279	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	0.00273	0.00273	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—FGFR3—cleft lip	0.00272	0.00272	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—FGFR3—cleft lip	0.00272	0.00272	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—WNT3—cleft lip	0.00272	0.00272	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—FGFR3—cleft lip	0.00269	0.00269	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—FGFR3—cleft lip	0.00267	0.00267	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—FGFR3—cleft lip	0.00266	0.00266	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGF7—cleft lip	0.00263	0.00263	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SPRY2—cleft lip	0.00263	0.00263	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—FGF10—cleft lip	0.00262	0.00262	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.00255	0.00255	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—PTCH1—cleft lip	0.00252	0.00252	CbGpPWpGaD
Vardenafil—PDE1B—Disease—WNT9B—cleft lip	0.00248	0.00248	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGF8—cleft lip	0.00243	0.00243	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGF7—cleft lip	0.00242	0.00242	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—FGF2—cleft lip	0.00241	0.00241	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.00241	0.00241	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MTR—cleft lip	0.00235	0.00235	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—WNT3—cleft lip	0.00233	0.00233	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—FGF2—cleft lip	0.00227	0.00227	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—MTR—cleft lip	0.00226	0.00226	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—FGF2—cleft lip	0.00226	0.00226	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IRF6—cleft lip	0.00225	0.00225	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—FGF2—cleft lip	0.00224	0.00224	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—FGF2—cleft lip	0.00223	0.00223	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGF8—cleft lip	0.00223	0.00223	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ABCA4—cleft lip	0.00221	0.00221	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—FGFR2—cleft lip	0.0021	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—FGF2—cleft lip	0.0021	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—FGF2—cleft lip	0.0021	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—FGF2—cleft lip	0.00208	0.00208	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—FGF2—cleft lip	0.00206	0.00206	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—FGF2—cleft lip	0.00205	0.00205	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SLC19A1—cleft lip	0.00202	0.00202	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGF7—cleft lip	0.00202	0.00202	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SPRY2—cleft lip	0.00202	0.00202	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—NOS3—cleft lip	0.00198	0.00198	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGF3—cleft lip	0.00198	0.00198	CbGpPWpGaD
Vardenafil—PDE1B—Disease—WNT3—cleft lip	0.00197	0.00197	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—FGFR1—cleft lip	0.00196	0.00196	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGF9—cleft lip	0.00193	0.00193	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.00186	0.00186	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGF8—cleft lip	0.00186	0.00186	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—FGFR3—cleft lip	0.00185	0.00185	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGF7—cleft lip	0.00184	0.00184	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SPRY2—cleft lip	0.00184	0.00184	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGF3—cleft lip	0.00182	0.00182	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGF7—cleft lip	0.0018	0.0018	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SPRY2—cleft lip	0.0018	0.0018	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGF9—cleft lip	0.00177	0.00177	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—NOS3—cleft lip	0.00176	0.00176	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—NOS3—cleft lip	0.00176	0.00176	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—MYC—cleft lip	0.00174	0.00174	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—WNT9B—cleft lip	0.00173	0.00173	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGF8—cleft lip	0.0017	0.0017	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TCN2—cleft lip	0.00167	0.00167	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PTCH1—cleft lip	0.00167	0.00167	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOG—cleft lip	0.00166	0.00166	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGF8—cleft lip	0.00166	0.00166	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGF10—cleft lip	0.00163	0.00163	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ABCA4—cleft lip	0.00155	0.00155	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—SUMO1—cleft lip	0.00154	0.00154	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PTCH1—cleft lip	0.00153	0.00153	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGF3—cleft lip	0.00151	0.00151	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGF10—cleft lip	0.00149	0.00149	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PTCH1—cleft lip	0.00149	0.00149	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGF9—cleft lip	0.00148	0.00148	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—FGF2—cleft lip	0.00143	0.00143	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGF7—cleft lip	0.00141	0.00141	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGF3—cleft lip	0.00139	0.00139	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—WNT3—cleft lip	0.00138	0.00138	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGF9—cleft lip	0.00135	0.00135	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGF3—cleft lip	0.00135	0.00135	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGF9—cleft lip	0.00132	0.00132	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGFR2—cleft lip	0.00131	0.00131	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SPRY2—cleft lip	0.0013	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF7—cleft lip	0.0013	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGF8—cleft lip	0.0013	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PTCH1—cleft lip	0.00128	0.00128	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MTHFR—cleft lip	0.00126	0.00126	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGF10—cleft lip	0.00125	0.00125	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGFR1—cleft lip	0.00122	0.00122	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF8—cleft lip	0.0012	0.0012	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGFR2—cleft lip	0.0012	0.0012	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTR—cleft lip	0.00116	0.00116	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGFR3—cleft lip	0.00115	0.00115	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGF10—cleft lip	0.00114	0.00114	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGFR1—cleft lip	0.00112	0.00112	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGF10—cleft lip	0.00111	0.00111	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGF3—cleft lip	0.00106	0.00106	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGFR3—cleft lip	0.00106	0.00106	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—MTR—cleft lip	0.00105	0.00105	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGF9—cleft lip	0.00103	0.00103	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGFR2—cleft lip	0.001	0.001	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF3—cleft lip	0.000977	0.000977	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF9—cleft lip	0.000953	0.000953	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGFR1—cleft lip	0.000932	0.000932	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGFR2—cleft lip	0.000914	0.000914	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF7—cleft lip	0.000911	0.000911	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SPRY2—cleft lip	0.000911	0.000911	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—NOS3—cleft lip	0.000894	0.000894	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGFR2—cleft lip	0.000891	0.000891	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGF2—cleft lip	0.000889	0.000889	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGFR3—cleft lip	0.000881	0.000881	CbGpPWpGaD
Vardenafil—PDE6G—Disease—NOS3—cleft lip	0.000877	0.000877	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGF10—cleft lip	0.00087	0.00087	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGFR1—cleft lip	0.000852	0.000852	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF8—cleft lip	0.000841	0.000841	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGFR1—cleft lip	0.000831	0.000831	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGF2—cleft lip	0.000816	0.000816	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGFR3—cleft lip	0.000805	0.000805	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF10—cleft lip	0.000804	0.000804	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGFR3—cleft lip	0.000785	0.000785	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTCH1—cleft lip	0.000755	0.000755	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGFR2—cleft lip	0.000698	0.000698	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF3—cleft lip	0.000684	0.000684	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGF2—cleft lip	0.000681	0.000681	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC19A1—cleft lip	0.000673	0.000673	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOS3—cleft lip	0.000671	0.000671	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF9—cleft lip	0.000667	0.000667	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGFR1—cleft lip	0.000651	0.000651	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGFR2—cleft lip	0.000645	0.000645	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGF2—cleft lip	0.000622	0.000622	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTHFR—cleft lip	0.000621	0.000621	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGFR3—cleft lip	0.000615	0.000615	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOS3—cleft lip	0.000614	0.000614	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGF2—cleft lip	0.000607	0.000607	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGFR1—cleft lip	0.000601	0.000601	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOS3—cleft lip	0.000598	0.000598	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MYC—cleft lip	0.000581	0.000581	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGFR3—cleft lip	0.000568	0.000568	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF10—cleft lip	0.000563	0.000563	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TCN2—cleft lip	0.000558	0.000558	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGF2—cleft lip	0.000475	0.000475	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGFR2—cleft lip	0.000452	0.000452	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—cleft lip	0.000445	0.000445	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF2—cleft lip	0.000439	0.000439	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS3—cleft lip	0.000433	0.000433	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGFR1—cleft lip	0.000421	0.000421	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—cleft lip	0.000407	0.000407	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGFR3—cleft lip	0.000398	0.000398	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—cleft lip	0.000397	0.000397	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTR—cleft lip	0.000387	0.000387	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC19A1—cleft lip	0.000313	0.000313	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF2—cleft lip	0.000307	0.000307	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOS3—cleft lip	0.000303	0.000303	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—cleft lip	0.000287	0.000287	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TCN2—cleft lip	0.000259	0.000259	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TYMS—cleft lip	0.000237	0.000237	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—cleft lip	0.000207	0.000207	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—cleft lip	0.000201	0.000201	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTR—cleft lip	0.00018	0.00018	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NOS3—cleft lip	0.000144	0.000144	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TYMS—cleft lip	0.00011	0.00011	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—cleft lip	9.62e-05	9.62e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NOS3—cleft lip	6.71e-05	6.71e-05	CbGpPWpGaD
